A group of British doctors are preparing for human clinical trials that will take a person’s bone marrow stem cells, transform them into heart stem cells and inject them into the heart, where they can go to work repairing damage.
“Placing heart stem cells into the heart to repair has a very good chance of working; because the stem cells are the patient’s own there are no problems with rejection,” said Professor Sian Harding, of Imperial College London.
The British researchers plan to use a technique that was pioneered at the Mayo Clinic. They will remove 40 milliliters of bone marrow
Stem cells are not invincible and therefore not likely to be the magic wand in the world of medicine, but they may be a great clue in finding what will be, a research professor explained on Thursday.
As part of a stem cell seminar series, Barbara Driscoll, Ph. D presented a lecture in the U Building titled “The Impact of Aging on Stem Cells.” The presentation covered basic information about stem cells, the aging process of mammals and how the two are so crucial to the next great discovery in medicine.
Driscoll is an assistant professor of Developmental Biology at USC
Image via Wikipedia
Don’t look for this just yet at your neighborhood clinic, but Minnesota scientists are pushing stem cell therapies into new frontiers — into territory that is so open that doctors and regulators still are shaping practices and policies as they go along.
In one breakthrough, researchers at Mayo Clinic in Rochester obtained stem cells derived from the bone marrow of heart disease patients and guided the cells to help heal, repair and regenerate damaged heart tissue. This is “landmark work,” said an editorial accompanying their research report in Monday’s Journal of the American College of Cardiology.
And last week,
Image via Wikipedia
The subject of producing artificial blood from stem cells has become a hot topic in Italy. “Italy is close to reaching the same objective announced by British researchers, on a similar timeframe,” therefore possibly in three years, “but using adult stem cells. Certainly, it is one thing to say that in three years we will begin the experimental phase, it’s another thing to speak about industrial production. It needs to be specified that the procedure to produce artificial blood is very expensive. Therefore this would be a complementary solution, which will not replace